Intermittent levosimendan infusion in ambulatory patients with end-stage heart failure: a systematic review and meta-analysis of 984 patients

We sought to synthesize the available evidence regarding safety and efficacy of intermittent levosimendan (LEVO) infusions in ambulatory patients with end-stage heart failure (HF). Safety and efficacy of ambulatory intermittent LEVO infusion in patients with end-stage HF are yet not established. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Elsherbini, Hagar, Soliman, Osama, Zijderhand, Casper, Lenzen, Mattie, Hoeks, Sanne E., Kaddoura, Rasha, Izham, Mohamed, Alkhulaifi, Abdulaziz, Omar, Amr S., Caliskan, Kadir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898255/
https://www.ncbi.nlm.nih.gov/pubmed/33839989
http://dx.doi.org/10.1007/s10741-021-10101-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898255/
https://www.ncbi.nlm.nih.gov/pubmed/33839989
http://dx.doi.org/10.1007/s10741-021-10101-0

Ejemplares similares